Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy assessment of ceftriaxone therapy in patients with amyotrophic lateral sclerosis
2007-004165-17Phase 2Completed
- Sponsor
- Azienda Ospedaliero-Universitaria Pisana
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ceftriaxone in amyotrophic lateral sclerosis (ALS), sponsored by Azienda Ospedaliero-Universitaria Pisana. Primary endpoint: Overall survival. Started Oct 2007; status: completed.
02
Drugs
ceftriaxone
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on 2007-004165-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004165-17.